Table of Contents
ISRN Pharmacology
Volume 2013, Article ID 713060, 8 pages
http://dx.doi.org/10.1155/2013/713060
Research Article

Anti-Inflammatory Effects of Hyptis albida Chloroform Extract on Lipopolysaccharide-Stimulated Peritoneal Macrophages

Departamento Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Colonia Villa Quietud, 04960 Mexico, DF, Mexico

Received 4 June 2013; Accepted 2 July 2013

Academic Editors: E. M. Urbanska and S.-N. Wu

Copyright © 2013 Elizabeth Sánchez Miranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Gautam and S. M. Jachak, “Recent developments in anti-inflammatory natural products,” Medicinal Research Reviews, vol. 29, no. 5, pp. 767–820, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. M. C. Allison, A. G. Howatson, C. J. Torrance, F. D. Lee, and R. I. Russell, “Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs,” The New England Journal of Medicine, vol. 327, no. 11, pp. 749–754, 1992. View at Google Scholar · View at Scopus
  3. M. S. Butler, “Natural products to drugs: natural product derived compounds in clinical trials,” Natural Product Reports, vol. 22, no. 2, pp. 162–195, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. R. M. Harley, “Revision of generic limits in Hyptis Jacq. (Labiatae) and its allies,” Botanical Journal of the Linnean Society, vol. 98, no. 2, pp. 87–95, 1988. View at Publisher · View at Google Scholar
  5. C. R. P. Franco, Â. R. Antoniolli, A. G. Guimarães et al., “Bioassay-guided evaluation of antinociceptive properties and chemical variability of the essential oil of Hyptis fruticosa,” Phytotherapy Research, vol. 25, no. 11, pp. 1693–1699, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. M. D. Bispo, R. H. V. Mourão, E. M. Franzotti et al., “Antinociceptive and antiedematogenic effects of the aqueous extract of Hyptis pectinata leaves in experimental animals,” Journal of Ethnopharmacology, vol. 76, no. 1, pp. 81–86, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. X. Bueno, A. T. S. Moreira, F. T. Silva, C. S. Estevam, and M. Marchioro, “Effects of the aqueous extract from Hyptis pectinata leaves on rodent central nervous system,” Revista Brasileira De Farmacognosia, vol. 16, no. 3, pp. 317–323, 2006. View at Publisher · View at Google Scholar
  8. C. R. P. Franco, P. B. Alves, D. M. Andrade et al., “Essential oil composition and variability in Hyptis fruticosa,” Brazilian Journal of Pharmacognosy, vol. 21, no. 1, pp. 24–32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Martínez, Catálogo De Nombres Vulgares Y Científicos De Plantas Mexicanas, Fondo de Cultura Económica, México, 1979.
  10. J. L. Díaz, Uso De Las Plantas Medicinales De México, Instituto Mexicano para el Estudio de las Plantas Medicinales A.C., México, 1976.
  11. R. Pereda-Miranda and G. Delgado, “Triterpenoids and flavonoids from Hyptis albida,” Journal of Natural Products, vol. 53, no. 1, pp. 182–185, 1990. View at Google Scholar · View at Scopus
  12. S. Pérez, B. L. Hernández, M. A. Zavala, G. E. Morales, and N. Cárdenas, “Antiinflammatory activity of Hyptis albida,” Journal of Medicinal Plants Research, vol. 6, no. 43, pp. 5582–5585, 2012. View at Google Scholar
  13. X. A. Domínguez, Métodos De Investigación Fitoquímica, Ed Limusa México, 1973.
  14. A. Elmann, S. Mordechay, H. Erlank, A. Telerman, M. Rindner, and R. Ofir, “Anti-Neuroinflammatory effects of the extract of Achillea fragrantissima,” BMC Complementary and Alternative Medicine, vol. 11, article 98, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. S. Ahn, E. J. Noh, H. L. Zhao, S. H. Jung, S. S. Kang, and Y. S. Kim, “Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon Grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells,” Life Sciences, vol. 76, no. 20, pp. 2315–2328, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Sánchez-González, D. Granados-Sánchez, and R. Simón-Nabor, “Medicinal uses of plants by the otomi towership nicolas flores, hidalgo México,” Revista Chapingo Series Horticulture, vol. 14, no. 3, pp. 271–279, 2008. View at Google Scholar
  17. N. T. Dung, V. K. Bajpai, J. I. Yoon, and S. C. Kang, “Anti-inflammatory effects of essential oil isolated from the buds of Cleistocalyx operculatus (Roxb.) Merr and Perry,” Food and Chemical Toxicology, vol. 47, no. 2, pp. 449–453, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. B. Reddy and P. Reddanna, “Chebulagic acid (CA) attenuates LPS-induced inflammation by suppressing NF-κB and MAPK activation in RAW 264.7 macrophages,” Biochemical and Biophysical Research Communications, vol. 381, no. 1, pp. 112–117, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. P.-H. Park, H. S. Kim, X. Y. Jin et al., “KB-34, a newly synthesized chalcone derivative, inhibits lipopolysaccharide-stimulated nitric oxide production in RAW 264.7 macrophages via heme oxygenase-1 induction and blockade of activator protein-1,” European Journal of Pharmacology, vol. 606, no. 1–3, pp. 215–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. S.-I. Kanno, A. Shouji, A. Tomizawa et al., “Inhibitory effect of naringin on lipopolysaccharide (LPS)-induced endotoxin shock in mice and nitric oxide production in RAW 264.7 macrophages,” Life Sciences, vol. 78, no. 7, pp. 673–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. I. Posadas, M. C. Terencio, I. Guillén et al., “Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 361, no. 1, pp. 98–106, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Moncada, R. M. J. Palmer, and E. A. Higgs, “Nitric oxide: physiology, pathophysiology, and pharmacology,” Pharmacological Reviews, vol. 43, no. 2, pp. 109–142, 1991. View at Google Scholar · View at Scopus
  23. D. Salvemini, Z.-Q. Wang, P. S. Wyatt et al., “Nitric oxide: a key mediator in the early and late phase of carrageenan-induced rat paw inflammation,” British Journal of Pharmacology, vol. 118, no. 4, pp. 829–838, 1996. View at Google Scholar · View at Scopus
  24. K. L. Davis, E. Martin, I. V. Turko, and F. Murad, “Novel effects of nitric oxide,” Annual Review of Pharmacology and Toxicology, vol. 41, pp. 203–236, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. A. R. Amin, P. Vyas, M. Attur et al., “The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 17, pp. 7926–7930, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. D. C. Rockey, J. J. Chung, C. M. McKee, and P. W. Noble, “Stimulation of inducible nitric oxide synthase in rat liver by hyaluronan fragments,” Hepatology, vol. 27, no. 1, pp. 86–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Li and I. M. Verma, “NF-κB regulation in the immune system,” Nature Reviews Immunology, vol. 2, no. 10, pp. 725–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. S. F. Liu and A. B. Malik, “NF-κB activation as a pathological mechanism of septic shock and inflammation,” American Journal of Physiology, vol. 290, no. 4, pp. L622–L645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. W. L. Smith, R. Michael Garavito, and D. L. DeWitt, “Prostaglandin endoperoxide H syntheses (cyclooxygenases)-1 and -2,” The Journal of Biological Chemistry, vol. 271, no. 52, pp. 33157–33160, 1996. View at Google Scholar · View at Scopus
  30. M. K. O'Banion, V. D. Winn, and D. A. Young, “cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 11, pp. 4888–4892, 1992. View at Publisher · View at Google Scholar · View at Scopus
  31. H. R. Herschman, “Prostaglandin synthase,” Biochimica et Biophysica Acta, vol. 1299, no. 1, pp. 125–140, 1996. View at Google Scholar · View at Scopus
  32. J. Clària, “Cyclooxigenase-2 biology,” Current Pharmaceutical Desing, vol. 9, pp. 2177–2190, 2003. View at Publisher · View at Google Scholar
  33. S. Zanotti, A. Kumar, and A. Kumar, “Cytokine modulation in sepsis and septic shock,” Expert Opinion on Investigational Drugs, vol. 11, no. 8, pp. 1061–1075, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. M. A. West, S. C. Seatter, J. Bellingham et al., “Mechanisms of reprogrammed macrophage endotoxin signal transduction after lipopolysaccharide pretreatment,” Surgery, vol. 118, no. 2, pp. 220–228, 1995. View at Publisher · View at Google Scholar · View at Scopus
  35. D. R. Hodge, E. M. Hurt, and W. L. Farrar, “The role of IL-6 and STAT3 in inflammation and cancer,” European Journal of Cancer, vol. 41, no. 16, pp. 2502–2512, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Mukhopadhyay, J. R. Hoidal, and T. K. Mukherjee, “Role of TNFα in pulmonary pathophysiology,” Respiratory Research, vol. 7, article 125, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Geiser, K. Atabai, P.-H. Jarreau, L. B. Ware, J. Pugin, and M. A. Matthay, “Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1β-dependent mechanism,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 6, pp. 1384–1388, 2001. View at Google Scholar · View at Scopus
  38. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” The New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Verma, S.-H. Li, M. V. Badiwala et al., “Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein,” Circulation, vol. 105, no. 16, pp. 1890–1896, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Tarighi, T. Kurum, M. Demir, and S. N. Azcan, “The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients,” Canadian Journal of Cardiology, vol. 23, no. 8, pp. 651–655, 2007. View at Google Scholar · View at Scopus
  41. D. Q. Falcão and F. S. Menezes, “Revisão etnofarmacológica, farmacológica e química do gênero Hyptis,” Revista Brasileira De Farmacognosia, vol. 84, no. 3, pp. 69–74, 2003. View at Google Scholar
  42. Y. M. Fan, L. Z. Xu, J. Gao et al., “Phytochemical and antiinflammatory studies on Terminalia catappa,” Fitoterapia, vol. 75, no. 3-4, pp. 253–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Suh, T. Honda, H. J. Finlay et al., “Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages,” Cancer Research, vol. 58, no. 4, pp. 717–723, 1998. View at Google Scholar · View at Scopus
  44. S. Y. Ryu, M.-H. Oak, S.-K. Yoon et al., “Anti-allergic and anti-inflammatory triterpenes from the herb of Prunella vulgaris,” Planta Medica, vol. 66, no. 4, pp. 358–360, 2000. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Shishodia, S. Majumdar, S. Banerjee, and B. B. Aggarwal, “Ursolic acid inhibits nuclear factor-κB activation induced by carcinogenic agents through suppression of IκBα kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1,” Cancer Research, vol. 63, no. 15, pp. 4375–4383, 2003. View at Google Scholar · View at Scopus
  46. T. Ishikawa, R. D. S. Donatini, I. E. C. Diaz, M. Yoshida, E. M. Bacchi, and E. T. M. Kato, “Evaluation of gastroprotective activity of Plinia edulis (Vell.) Sobral (Myrtaceae) leaves in rats,” Journal of Ethnopharmacology, vol. 118, no. 3, pp. 527–529, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. J. Lee, R. H. Son, H. W. Chang, S. S. Kang, and H. P. Kim, “Inhibition of arachidonate release from rat peritoneal macrophage by biflavonoids,” Archives of Pharmacal Research, vol. 20, no. 6, pp. 533–538, 1997. View at Google Scholar · View at Scopus
  48. W. J. Kwak, T. C. Moon, C. X. Lin et al., “Papyriflavonol a from Broussonetia papyrifera inhibits the passive cutaneous anaphylaxis reaction and has a secretory phospholipase A2-inhibitory activity,” Biological and Pharmaceutical Bulletin, vol. 26, no. 3, pp. 299–302, 2003. View at Google Scholar · View at Scopus
  49. D. S. Jang, M. Cuendet, M. E. Hawthorne et al., “Prenylated flavonoids of the leaves of Macaranga conifera with inhibitory activity against cyclooxygenase-2,” Phytochemistry, vol. 61, no. 7, pp. 867–872, 2002. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Landolfi, R. L. Mower, and M. Steiner, “Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations,” Biochemical Pharmacology, vol. 33, no. 9, pp. 1525–1530, 1984. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Horie, M. Tsukayama, H. Kourai et al., “Syntheses of 5,6,7- and 5,7,8-trioxygenated 3',4'-dihydroxyflavones having alkoxy groups and their inhibitory activities against arachidonate 5-lipoxygenase,” Journal of Medicinal Chemistry, vol. 29, no. 11, pp. 2256–2262, 1986. View at Google Scholar · View at Scopus
  52. G. R. Reddy, N. Ueda, T. Hada et al., “A prenylflavone, artonin E, as arachidonate 5-lipoxygenase inhibitor,” Biochemical Pharmacology, vol. 41, no. 1, pp. 115–118, 1991. View at Publisher · View at Google Scholar · View at Scopus
  53. M. J. Laughton, P. J. Evans, M. A. Moroney, J. R. S. Hoult, and B. Halliwell, “Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability,” Biochemical Pharmacology, vol. 42, no. 9, pp. 1673–1681, 1991. View at Publisher · View at Google Scholar · View at Scopus
  54. W. Krol, Z. P. Czuba, M. D. Threadgill, B. D. M. Cunningham, and G. Pietsz, “Inhibition of nitric oxide (NO·) production in murine macrophages by flavones,” Biochemical Pharmacology, vol. 50, no. 7, pp. 1031–1035, 1995. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Sadowska-Krowicka, E. E. Mannick, P. D. Oliver et al., “Genistein and gut inflammation: role of nitric oxide,” Proceedings of the Society for Experimental Biology and Medicine, vol. 217, no. 3, pp. 351–357, 1998. View at Google Scholar · View at Scopus
  56. Y. Geng, B. Zhang, and M. Lotz, “Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes,” Journal of Immunology, vol. 151, no. 12, pp. 6692–6700, 1993. View at Google Scholar · View at Scopus
  57. J. Y. Cho, P. S. Kim, J. Park et al., “Inhibitor of tumor necrosis factor-α production in lipopolysaccharide-stimulated RAW264.7 cells from Amorpha fruticosa,” Journal of Ethnopharmacology, vol. 70, no. 2, pp. 127–133, 2000. View at Publisher · View at Google Scholar · View at Scopus